They can exhibit sluggish biological behavior if associated with a POLE pathogenic variant; on the contrary, if associated with a TP53 pathogenic variant, they can be extremely aggressive, even overcoming serous carcinomas. Here, TP53 is linked to serous adenocarcinoma.